Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
Join us next week at #FDAs Patient Engagement Advisory Committee (Nov 15) to discuss patient-generated health data from sources like social media, activity trackers, and patient-driven registries. https://t.co/4FV8keOY1P #PEAC2018 https://t.co/NpD8eVYdJJ
SteveFDA (R-D.C.)
@SGottliebFDA
NEW RECORD: In October #FDA approved 110 generic drugs and tentatively approved 18 generic drugs, for a total of 128 approval actions. This included 23 first generics for brands that lacked competition and 17 complex generics. https://t.co/apBrf4olXX https://t.co/3YioKVIamK
SteveFDA (R-D.C.)
@SGottliebFDA
Through #FDA’s efforts, generic drugs entering the market from Jan. 2017 through July 2018 saved consumers $26 billion through the lower prices they enabled. We’ll continue our efforts to increase competition and help lower costs for patients. https://t.co/apBrf4olXX
SteveFDA (R-D.C.)
@SGottliebFDA
My statement today discusses steps to modernize our inspections program with a new way of assessing, recording and reporting the data from surveillance and pre-approval inspections for sterile drug products https://t.co/C2CjI8c4JK
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: OCE Director Richard Pazdur @realrickpazdur with ASCO Fellows at FDA White Oak campus providing perspectives on dru… https://t.co/HP0eTwK0uw
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: So proud of the @FDAOncology & @ASCO joint effort w/ #FDA_ASCOFellowsDay. Fantastic diversity in the room: 21 sta… https://t.co/K1HbgPoPg3
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: Gratitude to my friends & fellow program comm members, Drs. Suparna Wedam, @LalehAmiri, @drjennifergao, all our… https://t.co/TcNonnj91g
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: A few more shots from today’s #FDA_ASCOFellowsDay Workshop. Appreciated the enthusiasm from all the fellows & fun… https://t.co/UMAANzflqq
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: Meet #FDAOncology and other FDA staff and learn about opportunities for patient advocacy at our 2nd annual educatio… https://t.co/WUiRYSH7ve
SteveFDA (R-D.C.)
@SGottliebFDA
A new initiative by the #FDA seeks to help advance medical device-based treatments, diagnostic tests, and mobile medical apps that can help address the opioid crisis. https://t.co/LzyV0Bcmma
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: My deep concern about youth e-cig use, and my goal of advancing innovations to help adult smokers quit, stems from… https://t.co/NJTLm8Fksw
SteveFDA (R-D.C.)
@SGottliebFDA
Under the MOU, the #FDA will work closely to expedite review of priority DoD medical products; provide for rapid development and manufacturing of medical products; and determine opportunities for streamlining review for the priority products that are currently under development.
SteveFDA (R-D.C.)
@SGottliebFDA
It takes a talented, dedicated professional staff to do this vital work. FDA is honored that over 1,200 veterans, or 7% of our current staff, chose to continue to serve their country in roles at #FDA. https://t.co/wEjuXqjaMO. And we still have mission-critical vacancies to fill
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Drug_Info: We’re in San Diego for #APHA2018! Stop by Exhibit #2238 to learn how to stay up to date with important drug informa… https://t.co/2MZVOsWdeV
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSGov: On #VeteransDay we honor all veterans for their selfless service to our nation ��. At HHS, we especially salute th… https://t.co/SGzIFXjDLw
SteveFDA (R-D.C.)
@SGottliebFDA
RT @Surgeon_General: “To truly improve the health of our nation, it is imperative that we lift up those who are most disadvantaged by pr… https://t.co/LWjE4HY41r
SteveFDA (R-D.C.)
@SGottliebFDA
ICYMI: FDA is honored to announce the kick off of the Veterans Viewpoint, a virtual recruitment effort dedicated to serving veterans and persons with disabilities. Visit https://t.co/h7SUD5mjDF under Veterans and Jobseekers with Disabilities. #veterans
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: U.S soldiers go to extreme locations and face untold physical risk to defend us, resulting in unique medical needs.… https://t.co/uY7RLSaJCf
SteveFDA (R-D.C.)
@SGottliebFDA
With the wide changing standard of care towards transformative immuno-oncology products across many areas of cancer, #FDA is evaluating immune-based criteria and potential for these to serve as the primary evidence to support approval of novel cancer drugs https://t.co/EXmo51XmJj
SteveFDA (R-D.C.)
@SGottliebFDA
In October #FDA set a new record for generic approvals with 110 generic drugs approved and 18 tentatively approved; for a total of 128 approval actions. These figures include 23 first generics for brands that lacked competition and 17 new complex generics. https://t.co/TxYLX6Ge6J https://t.co/FwaVjlJErk